AMENDMENT NO. 1 TO LICENSE AGREEMENTLicense Agreement • April 19th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Contract Type FiledApril 19th, 2017 Company IndustryThis Amendment No. 1 to License Agreement (this “Amendment”) is made as of December 13, 2016, by and among Opiant Pharmaceuticals, Inc. (formerly known as Lightlake Therapeutics Inc.), a Nevada corporation (“Opiant”), and Adapt Pharma Operations Limited, an Irish limited company (“Adapt”). Opiant and Adapt are sometimes referred to herein individually as a “Party” and collectively as the “Parties”. Capitalized terms used but not defined herein have the meanings given to them in the License Agreement (as defined below).
AMENDMENT NO. 1 TO LICENSE AGREEMENTLicense Agreement • March 15th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Contract Type FiledMarch 15th, 2017 Company IndustryThis Amendment No. 1 to License Agreement (this “Amendment”) is made as of December 13, 2016, by and among Opiant Pharmaceuticals, Inc. (formerly known as Lightlake Therapeutics Inc.), a Nevada corporation (“Opiant”), and Adapt Pharma Operations Limited, an Irish limited company (“Adapt”). Opiant and Adapt are sometimes referred to herein individually as a “Party” and collectively as the “Parties”. Capitalized terms used but not defined herein have the meanings given to them in the License Agreement (as defined below).